PatientPartner Appoints Dr. Jeffrey Kasher to Board of Directors

PatientPartner has appointed Jeffrey Kasher, PhD, to its Board of Directors, effective August 11, 2026. The 28-year pharmaceutical industry veteran brings deep experience in clinical development, patient engagement, and implementing new models within large life sciences organizations. ^[1]

His appointment comes as PatientPartner expands its work with pharmaceutical and clinical trial sponsors and scales its mentor-driven engagement model across life sciences.

Key Takeaways

• Dr. Kasher spent 28 years at Eli Lilly and held senior leadership roles across global clinical development and clinical innovation.
• His sponsor-side experience will help PatientPartner design patient-engagement programs that fit complex clinical-development environments.
• The appointment strengthens PatientPartner’s clinical trial expertise as the company expands its work across recruitment, retention, treatment adoption, and adherence.

Clinical Development Experience at Enterprise Scale

At Eli Lilly, Dr. Kasher rose to Vice President and Chief Operating Officer of the Global Clinical Development Organization and Vice President of Clinical Innovation and Implementation.

That experience gives him a practical understanding of both the challenges sponsors face and what it takes to put meaningful change into practice across a global organization.

“Jeff spent nearly three decades inside one of the world’s largest pharmaceutical companies and understands both the challenges sponsors face and what it takes to implement meaningful change at scale,” said George Kramb, CEO and Co-Founder of PatientPartner. “As we expand our clinical trial business, his experience gives us invaluable perspective on how patient engagement can become a more integrated part of clinical development. His judgment, industry relationships, and ability to bridge innovation with the realities of pharma will be incredibly valuable as we enter our next stage of growth.”

Connecting Patient Engagement With Clinical Development

Since leaving Eli Lilly, Dr. Kasher has continued working at the intersection of clinical development, patient engagement, and innovation. He is President of Patients Can’t Wait, Chairman of the Board of Directors at Javara, an independent director at Univo, and a strategic advisor to Cognivia.

He also advises pharmaceutical companies, contract research organizations, and emerging technology companies on clinical-development strategy and implementation.

This combination of sponsor-side leadership and hands-on work with emerging clinical trial models will help PatientPartner strengthen its approach to patient retention, engagement, and recruitment while building programs designed to integrate into the operating environments of global life sciences companies.

Keeping Patients Engaged Throughout the Trial

PatientPartner’s clinical trial engagement platform connects participants with mentors who have navigated similar health experiences. The model gives patients access to a trusted peer who can help them feel informed, supported, and understood throughout a demanding trial experience.

“What drew me to PatientPartner is its focus on one of the most persistent challenges in clinical development: keeping patients engaged once they’ve enrolled in a trial,” said Dr. Kasher. “Participation can be a long and demanding journey, and too often patients are expected to navigate that experience without the support of someone who truly understands what they’re going through. PatientPartner’s mentor-driven model creates that connection, giving patients a trusted peer who can help them stay informed, supported, and engaged throughout the trial. I’m excited to work with George and the board to bring that approach to more patients and sponsors.”

Guiding PatientPartner’s Next Stage of Growth

Dr. Kasher’s appointment strengthens PatientPartner’s clinical-development expertise as the company scales its work across life sciences.

His experience will help guide PatientPartner’s work with sponsors to integrate peer mentorship into the patient experience, from clinical trial recruitment and retention through treatment adoption and long-term adherence.

Learn more about PatientPartner’s clinical trial engagement solutions.

About PatientPartner

PatientPartner operates a mentor-driven patient connectivity platform that matches patients and their caregivers with peers who have navigated similar healthcare experiences. The company works with pharmaceutical, medical device, and clinical trial organizations to improve patient adoption, adherence, and trial recruitment and retention.

Frequently Asked Questions

When did Dr. Jeffrey Kasher join PatientPartner’s Board of Directors?

Dr. Jeffrey Kasher joined PatientPartner’s Board of Directors effective August 11, 2026.

What experience does Dr. Jeffrey Kasher bring to PatientPartner?

Dr. Kasher brings 28 years of pharmaceutical industry leadership from Eli Lilly, including senior roles in global clinical development, clinical innovation, and implementation.

How will Dr. Kasher support PatientPartner’s growth?

Dr. Kasher will help guide PatientPartner’s work with pharmaceutical and clinical trial sponsors as the company integrates peer mentorship across recruitment, retention, treatment adoption, and long-term adherence programs.